Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025)
Cabaletta Bio (CABA) recorded quarterly Interest & Investment Income of $1.3 million in Q4 2025, down 26.66% quarter-over-quarter from $1.8 million in Q3 2025, and down 31.9% on a YoY basis from $1.9 million in Q4 2024.
Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025) Analysis & Trends
Cabaletta Bio's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- In Q4 2025, Interest & Investment Income fell 31.9% year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $6.0 million (down 39.84% YoY), while the FY2025 annual figure was $6.0 million, down 39.84% from the prior year.
- Interest & Investment Income was $1.3 million for Q4 2025 at Cabaletta Bio, down from $1.8 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q1 2024 to a low of $3000.0 in Q3 2021.
- Historically, Interest & Investment Income has averaged $1.2 million across 5 years, with a median of $1.4 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Interest & Investment Income plunged 97.56% in 2021, then soared 12100.0% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $5000.0 in 2021, then jumped by 12100.0% to $610000.0 in 2022, then surged by 270.49% to $2.3 million in 2023, then dropped by 13.85% to $1.9 million in 2024, then slumped by 31.9% to $1.3 million in 2025.
- The last three Interest & Investment Income figures came in at $1.3 million (Q4 2025), $1.8 million (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Cabaletta Bio | 151.84 Mn | 18.24 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 610,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 10,000.00 |